Cargando…
Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression
Autosomal dominant polycystic kidney disease (ADPKD) affects more than 500,000 individuals in the United States alone. In most cases, ADPKD is caused by a loss-of-function mutation in the PKD1 gene, which encodes polycystin-1 (PC1). Previous studies reported that PC1 interacts with atypical protein...
Autores principales: | Akbari, Masaw, West, Jonathan D., Doerr, Nicholas, Kipp, Kevin R., Marhamati, Neda, Vuong, Sabrina, Wang, Yidi, Rinschen, Markus M., Talbot, Jeffrey J., Wessely, Oliver, Weimbs, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335328/ https://www.ncbi.nlm.nih.gov/pubmed/35867829 http://dx.doi.org/10.1073/pnas.2121267119 |
Ejemplares similares
-
Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease
por: Weimbs, Thomas, et al.
Publicado: (2018) -
Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022) -
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects
por: Strubl, Sebastian, et al.
Publicado: (2021) -
Developments in the management of autosomal dominant polycystic
kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)